Apeloa Pharmaceutical Co., Ltd, established in 1989, is a prominent pharmaceutical company in China. It operates under Hengdian Group and is involved in the research, development, and production of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and finished dosage forms (FDF). The company is recognized for its high-tech capabilities and comprehensive services in the API, CDMO, and FDF sectors. Apeloa has multiple R&D and manufacturing facilities in China and maintains strategic partnerships with top pharmaceutical and biotech companies worldwide. The company is committed to sustainable practices and high-quality standards, holding certifications such as GMP, ISO9001, ISO14001, and OSHAS18001.